Stocks
Fate Therapeutics (FATE) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -914.9% | -541.8% | -369.4% | -264.9% | -253.3% | -1 325% | ||
| Changes by years, y/y, % | +490pp | +373pp | +172pp | +105pp | +12pp | -29.0% | |||
Fate Therapeutics. Net margin, %
Fate Therapeutics. Net margin, changes, pp
Fate Therapeutics (FATE) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | -2 324% | -2 633% | -2 494% | -567.4% | -1 551% | -1 325% | |
| Changes by years, y/y, % | -1 785pp | -2 524pp | -2 478pp | +5 087pp | +773pp | |||
| Changes by quarters, q/q, % | +3 331pp | -309pp | +139pp | +1 926pp | -984pp | |||
